Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder

• DOI: 10.1093/hmg/ddr416
• Publication Date: 2011-09-09T23:58:49Z
• Authors: Emma L. Dempster; Ruth Pidsley; Leonard C. Schalkwyk; Sheena Owens; Anna Georgiades; Fergus Kane; Sridevi Kalidindi; Marco Picchioni; Eugenia Kravariti; Timothea Toulopoulou; Robin M. Murray; Jonathan Mill
• Keywords: Male; 0301 basic medicine; 570; Bipolar Disorder; Cpg Islands - Genetics; Twins; 610; QH426 Genetics; Epigenesis, Genetic; Promoter Regions; Young Adult; 03 medical and health sciences; Genetic; Humans; Gene Regulatory Networks; Genetic Predisposition to Disease; Promoter Regions, Genetic; Monozygotic - Genetics; Bipolar Disorder - Genetics; Demography; Genome; Genome, Human; Reproducibility of Results; Dna Methylation - Genetics; Articles; Twins, Monozygotic; Schizophrenia - Genetics; DNA Methylation; Genetic Predisposition To Disease; 3. Good health; Genome, Human - Genetics; Twins, Monozygotic - Genetics; Human - Genetics; Schizophrenia; Gene Regulatory Networks - Genetics; CpG Islands; Female; Reproducibility Of Results; Epigenesis

Studies of the major psychoses, schizophrenia (SZ) and bipolar disorder (BD), have traditionally focused on genetic and environmental risk factors, although more recent work has highlighted an additional role for epigenetic processes in mediating susceptibility. Since monozygotic (MZ) twins share a common DNA sequence, their study represents an ideal design for investigating the contribution of epigenetic factors to disease etiology. We performed a genome-wide analysis of DNA methylation on peripheral blood DNA samples obtained from a unique sample of MZ twin pairs discordant for major psychosis. Numerous loci demonstrated disease-associated DNA methylation differences between twins discordant for SZ and BD individually, and together as a combined major psychosis group. Pathway analysis of our top loci highlighted a significant enrichment of epigenetic changes in biological networks and pathways directly relevant to psychiatric disorder and neurodevelopment. The top psychosis-associated, differentially methylated region, significantly hypomethylated in affected twins, was located in the promoter of ST6GALNAC1 overlapping a previously reported rare genomic duplication observed in SZ. The mean DNA methylation difference at this locus was 6%, but there was considerable heterogeneity between families, with some twin pairs showing a 20% difference in methylation. We subsequently assessed this region in an independent sample of postmortem brain tissue from affected individuals and controls, finding marked hypomethylation (>25%) in a subset of psychosis patients. Overall, our data provide further evidence to support a role for DNA methylation differences in mediating phenotypic differences between MZ twins and in the etiology of both SZ and BD.